Literature DB >> 35648479

UG/Abi: a highly diverse family of prokaryotic reverse transcriptases associated with defense functions.

Mario Rodríguez Mestre1, Linyi Alex Gao2,3,4,5, Shiraz A Shah6, Adrián López-Beltrán7, Alejandro González-Delgado8, Francisco Martínez-Abarca8, Jaime Iranzo7,9, Modesto Redrejo-Rodríguez1, Feng Zhang2,3,4,10,11, Nicolás Toro8.   

Abstract

Reverse transcriptases (RTs) are enzymes capable of synthesizing DNA using RNA as a template. Within the last few years, a burst of research has led to the discovery of novel prokaryotic RTs with diverse antiviral properties, such as DRTs (Defense-associated RTs), which belong to the so-called group of unknown RTs (UG) and are closely related to the Abortive Infection system (Abi) RTs. In this work, we performed a systematic analysis of UG and Abi RTs, increasing the number of UG/Abi members up to 42 highly diverse groups, most of which are predicted to be functionally associated with other gene(s) or domain(s). Based on this information, we classified these systems into three major classes. In addition, we reveal that most of these groups are associated with defense functions and/or mobile genetic elements, and demonstrate the antiphage role of four novel groups. Besides, we highlight the presence of one of these systems in novel families of human gut viruses infecting members of the Bacteroidetes and Firmicutes phyla. This work lays the foundation for a comprehensive and unified understanding of these highly diverse RTs with enormous biotechnological potential.
© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35648479      PMCID: PMC9226505          DOI: 10.1093/nar/gkac467

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   19.160


  87 in total

1.  Multiple origins of reverse transcriptases linked to CRISPR-Cas systems.

Authors:  Nicolás Toro; Francisco Martínez-Abarca; Mario Rodríguez Mestre; Alejandro González-Delgado
Journal:  RNA Biol       Date:  2019-07-11       Impact factor: 4.652

2.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

3.  COG database update: focus on microbial diversity, model organisms, and widespread pathogens.

Authors:  Michael Y Galperin; Yuri I Wolf; Kira S Makarova; Roberto Vera Alvarez; David Landsman; Eugene V Koonin
Journal:  Nucleic Acids Res       Date:  2020-11-09       Impact factor: 16.971

4.  DALI and the persistence of protein shape.

Authors:  Liisa Holm
Journal:  Protein Sci       Date:  2019-11-05       Impact factor: 6.725

5.  Expression and site-directed mutagenesis of the lactococcal abortive phage infection protein AbiK.

Authors:  Louis-Charles Fortier; Julie D Bouchard; Sylvain Moineau
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

6.  Diversity and classification of cyclic-oligonucleotide-based anti-phage signalling systems.

Authors:  Adi Millman; Sarah Melamed; Gil Amitai; Rotem Sorek
Journal:  Nat Microbiol       Date:  2020-08-24       Impact factor: 17.745

7.  NCBI's Conserved Domain Database and Tools for Protein Domain Analysis.

Authors:  Mingzhang Yang; Myra K Derbyshire; Roxanne A Yamashita; Aron Marchler-Bauer
Journal:  Curr Protoc Bioinformatics       Date:  2020-03

8.  Massive expansion of human gut bacteriophage diversity.

Authors:  Luis F Camarillo-Guerrero; Alexandre Almeida; Guillermo Rangel-Pineros; Robert D Finn; Trevor D Lawley
Journal:  Cell       Date:  2021-02-18       Impact factor: 41.582

9.  CD-HIT: accelerated for clustering the next-generation sequencing data.

Authors:  Limin Fu; Beifang Niu; Zhengwei Zhu; Sitao Wu; Weizhong Li
Journal:  Bioinformatics       Date:  2012-10-11       Impact factor: 6.937

10.  PLSDB: a resource of complete bacterial plasmids.

Authors:  Valentina Galata; Tobias Fehlmann; Christina Backes; Andreas Keller
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.